Recent research offers pivotal insights into biomarkers and molecular mechanisms across oncology and chronic conditions. Elevated serum neopterin and kynurenine levels predict prostate cancer prognosis (a5044c9b7daa8fd3). Lactylation signatures provide novel risk stratification in prostate cancer (4efe3f99d9cc3116). ECMO combined with neurally adjusted ventilation shows promise in critical care (b1f5c749f511d967). CX26 stabilizes oncogenic c-Myc fueling pancreatic cancer progression (b9c4d6d42b395d3a). Additionally, ferroptosis contributes to liver injury post-transplantation (be7dd92124eb7524). These molecular insights pave the way for precision diagnostics and targeted therapeutic interventions.